Juan I. Arostegui
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications
How multi-omic technologies can help define paediatric undifferentiated systemic autoinflammatory diseases: the experience of the European PerSAIDs consortium.
Journal: RMD open
Published: February 19, 2026
IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.
IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.
Journal: The Journal of experimental medicine
Published: August 26, 2025
Clinical characteristics and a screening tool for VEXAS syndrome: a case-control study from China.
Journal: Orphanet journal of rare diseases
Published: July 31, 2025
Clinical and Immunological Impact of JAK Inhibition in Concurrent Down Syndrome and STAT1 Gain of Function.
Journal: Journal of clinical immunology
Published: July 03, 2025
Protective Effects of Interleukin-1 Inhibition With Anakinra in Mouse Models of Ischemic Stroke With and Without Reperfusion.
Journal: Journal of the American Heart Association
Published: May 02, 2025
Somatic NLRP3 mosaicism in patients with "mutation-negative" CAPS: insights from a single centre UK cohort.
Journal: Frontiers in pediatrics
Published: March 23, 2025
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 Mosaicism.
Journal: Journal of clinical immunology
Published: January 19, 2025
Anifrolumab Treatment in Cutaneous Lupus Erythematosus with and without systemic involvement: A Retrospective Study.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: January 17, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 13, 2024
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 13, 2024
Refractory Dermatomyositis Treated With Anifrolumab: Clinical Response and Dynamics of Type-I Interferon Signature.
Journal: Actas dermo-sifiliograficas
Published: November 28, 2024
The inflammasome adaptor protein ASC promotes amyloid deposition in cryopyrin-associated periodic syndromes.
Journal: EMBO molecular medicine
Published: September 23, 2024
Last Updated: 09/26/2026